This is the official Google+ page for Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients.
Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics.
Teva currently employs approximately 47,000 people around the world and reached $16.1 billion in net sales in 2010.
Note to Users: This page is intended to provide news and updates about our company, and Teva reserves the right to delete any comments that it considers to be inappropriate, abusive or spam.
Adverse events for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details may be found here: http://www.tevapharm.com/en-US/Pages/Contact-Us.aspx
“The relationship between Teva, Israel and the UK is a long and fruitful one and I am proud that we can now add another example of us working together as partners for innovation and health,” stated Dr. Michael Hayden, Teva’s President of Global R&D and Chief Scientific Officer.
The collaboration was announced in the presence of UK Prime Minister, David Cameron, Israel Prime Minister, Binyamin Netanyahu, and Teva’s President and CEO Erez Vigodman at a special UK-Israel Tech Hub at the British Embassy Israel event held at Teva’s Jerusalem site (pictured below).
Read the full article: http://www.tevapharm.com/Media/News/Pages/2014/1908731.aspx
We’re excited to work together with VIM to achieve our mutual goals of making health care more accessible.
Nuestra fábrica en Zaragoza sigue creciendo año a año. Solo en 2013, se han producido 3.700 millones de dosis, que equivalen a 125 millones de unidades de producto terminado, destinado al propio mercado español a Europa España y Chile. Nuestro compromiso con los pacientes es asegurar que nuestros medicamentos de calidad estarán disponibles en todo el mundo y en el menor tiempo posible. Siga nuestros colegas de Teva Pharma España para todas las últimas noticias locales!
A new initiative and nationwide campaign titled “You are the Hero” was recently launched in Hungary to teach effective resuscitation techniques. Zalán Mészáros, a sales representative at Teva Hungary, served as a paramedic for 19 years and has been training his fellow employees in an easy to learn resuscitation technique to help save lives and make a real difference! http://www.tevapharm.com/Media/EventsUpdates/Pages/teva-hungary-yuu-are-the-hero.aspx